Financial Architects, Inc Fortress Biotech, Inc. Transaction History

Financial Architects, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$1.43 - $1.94 $572 - $776	-400 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$0.94 - $2.47 $376 - $988	400 New	400 $1,000
Q1 2019 May 03, 2019	SELL	$0.94 - $2.47 $376 - $988	-400 Closed	0 $0
Q3 2017 Nov 01, 2017	BUY	$3.83 - $4.89 $1,532 - $1,955	400	400 $2,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $229M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.